ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0897

Age-Stratified Trend of Spinal Radiographic Damage Progression in Patients with Ankylosing Spondylitis

Tae-Han Lee1, Bon San Koo2, Bora Nam3, Seunghun Lee4, Kyung Bin Joo4 and Tae-Hwan Kim3, 1Keimyung University Dongsan Hospital, Daegu, Republic of Korea, 2Inje University Seoul Paik Hospital, Seoul, Republic of Korea, 3Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 4Hanyang University Hospital, Seoul, Republic of Korea

Meeting: ACR Convergence 2021

Keywords: Aging, Ankylosing spondylitis (AS), longitudinal studies, radiography, risk factors

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster II: Imaging in Spondyloarthritis (0897–0907)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Previous studies investigating the course of spinal structural progression in patients with ankylosing spondylitis (AS) using the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) have shown highly variable rates of mSASSS progression among individuals. Furthermore, a substantial radiographic progression has been noted both in young patients at an early stage of disease as well as in elderly patients at an advanced stage, indicating a within-individual variation in the progression of long-term structural damage in the spine. Thus, exploring the extent to which spinal radiographic damage worsens according to age can be helpful in providing insights into the understanding of the natural course of structural disease progression. The aim of this study was to estimate the course of spinal radiographic progression for specific age range categories using a longitudinal dataset in a real-life setting.

Methods: In total, 4016 radiographic intervals were obtained from 1125 AS patients with consecutive spinal radiographs available at a single hospital. The included radiographic intervals were categorized into five groups based on the age at each radiograph: age < 20 (n=122); 20–29 (n=1124); 30–39 (n=690); 40–49 (n=794); and ≥50 years (n=286). Radiographic progression rate was defined as the mSASSS change per year. Age-stratified mSASSS change per year was estimated using the generalized estimating equations (GEE) for longitudinal data after adjusting for predictors of radiographic progression. A subgroup analysis was performed to estimate the course of radiographic progression, stratified for identified risk factors.

Results: The mean (SD) follow-up duration was 8.4 (2.9) years and the mean number of radiographs was 4.6 (1.2) per patient. The mean radiographic progression rate of the overall intervals was 0.8 (1.9). In the GEE multivariable analysis, smoking, peripheral joint involvement, eye involvement, log-transformed C-reactive protein (CRP) values at each radiograph, and preexisting syndesmohyte were significant and independent factors for predicting structural damage progression.
GEE-estimated radiographic progression was highest at age group 30–39 (estimated mean mSASSS change per year was 1.148), followed by 40–49 (1.003), 20–29 (0.868), ≥50 (0.779), and < 20 (0.643) . However, radiographic damage scores rapidly increased among younger age groups with risk factors. The estimated mean mSASSS change per year for the age group 20–29 was 1.244 with elevated CRP levels and 2.505 with preexisting syndesmophytes, respectively.

Conclusion: In AS, spinal structural damage with age progresses in an increasing trend in which periods of relatively rapid increase and slow increase may alternate, and it seems to progress the most in the 30s. However, patients with risk factors show a rapid progression from under the 30s.


Disclosures: T. Lee, None; B. Koo, None; B. Nam, None; S. Lee, None; K. Joo, None; T. Kim, AbbVie, 6, Celltrion, 6, Kirin, 6, Lilly, 6, Novartis, 6.

To cite this abstract in AMA style:

Lee T, Koo B, Nam B, Lee S, Joo K, Kim T. Age-Stratified Trend of Spinal Radiographic Damage Progression in Patients with Ankylosing Spondylitis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/age-stratified-trend-of-spinal-radiographic-damage-progression-in-patients-with-ankylosing-spondylitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/age-stratified-trend-of-spinal-radiographic-damage-progression-in-patients-with-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology